Key risk factors include: History of Gallstones: These can obstruct the pancreatic duct, leading to inflammation
Fiber is essential during semaglutide treatment to maintain digestive regularity
If a vial is used, who trains the user and supplies calibrated syringes
The Medicines and Healthcare products Regulatory Agency (MHRA) provides detailed pharmacokinetic information in the Summary of Product Characteristics for each GLP-1 receptor agonist, which healthcare professionals use to guide prescribing decisions
Some patients may take weeks or months to correctly adjust their dosage to begin seeing weight loss
With significant or rapid weight loss, particularly when driven by GLP-1 drugs, several mechanisms converge: Loss of underlying fat volume removes structural support Collagen and elastin fibres become stretched and fragmented Speed of weight loss outpaces skin contraction While some rebound occurs naturally, significant laxity can be permanent, especially after large weight reductions